Pipette Inserted Into Test Tube

EpiLAB test

The answer to underdiagnosis of Tuberculosis in developing countries

Portable

No infrastructure needed

Sensitive

No false negative result

Easy to use

No qualification needed

Affordable

Adapted to affected countries

Wix.jpg

Tuberculosis diagnosis gap in figures

 

10 million new cases each year

Each year, 10 million people contract with tuberculosis. One-third of these new cases, about 3 million, are not detected and remain unknown to health organizations. Therefore they are not receiving proper treatment they need and deserve, and increase contamination.

3 million undetected cases

​Eighty percents of new yearly cases emerge in developing countries who lack of resources to afford and deploy sufficient diagnosis campaign. Existing tests are not adapted to the needs of those countries. The main issues are:

  • Infrastructure (labs) required : most of the population does not have an easy access to the few existing infrastructure

  • Medically qualified staff required

  • High prices

  • Unquantifiable and not sensitive tests

1.5 million victims

Despite being a preventable and curable disease, due to underdiagnosis, 1.5 million people die from TB each year, making it the world’s top infectious killer.

Reference : World Health Organization

How we do it

We leverage a patented tuberculosis detection method using specific enzymatic reactions coupled with electrochemical detection.

Experiment
 

Our team

Maurice Lubetzki

 CTO

Entrepreneur, Engineer

Clément Dubois

CEO

Entrepreneur, Engineer

Murielle Rochelet

CSO, inventor

PhD in Electrochemistry

Elodie Barbier

Inventor

PhD in Mycobacteria

 

Contact us

4 rue Anatole France, 78350, Jouy-en-Josas, France

C. Dubois : +33 6 04 15 71 54

M. Lubetzki : +33 6 47 71 54 32

  • LinkedIn
 

©2020 par EpiLAB